Furthermore, a recent systematic review suggests that in insulin-treated T2DM, insulin degludec/insulin aspart 70/30 twice daily is comparable to biphasic insulin aspart 30 twice daily and imposes a lower risk of nocturnal hypoglycemia [101]. Here, INS is linked to Hypoglycemia.